In addition, it was revealed that GHRH antagonists MZ-J-7-138 or JV-1-92, in combination with docetaxel, reduced the ERK upstream protein K-RAS and COX-2 in mice xenografted with non-small cell lung cancer cells (NSCLCs) [40]. Here, KRAS is linked to non-small cell lung carcinoma.